The Atrial Fibrillation Devices Market is witnessing significant growth as the global burden of cardiac arrhythmias continues to rise. Atrial fibrillation (AF) remains one of the most common heart rhythm disorders worldwide, increasing the risk of stroke, heart failure, and other cardiovascular complications. In 2024, the market was valued at US$ 25,789 million and is projected to expand at a...